DON’T MISS
IamExpat FairIamExpat Job BoardIamExpat Webinars
Newsletters
EXPAT INFO
CAREER
HOUSING
EDUCATION
LIFESTYLE
EXPAT SERVICES
NEWS & ARTICLES
Home
Expat Info
German news & articles
Moderna COVID-19 vaccine given approval by EU health authority
Never miss a thing!Sign up for our weekly newsletters with important news stories, expat events and special offers.
Keep me updated with exclusive offers from partner companies
By signing up, you agree that we may process your information in accordance with our privacy policy

Moderna COVID-19 vaccine given approval by EU health authority

Never miss a thing!Sign up for our weekly newsletters with important news stories, expat events and special offers.
Keep me updated with exclusive offers from partner companies
By signing up, you agree that we may process your information in accordance with our privacy policy
or
follow us for regular updates:



Related Stories

When will I get my coronavirus vaccination in Germany?When will I get my coronavirus vaccination in Germany?
Second Omicron booster jab gets green light from European Medicines AgencySecond Omicron booster jab gets green light from European Medicines Agency
Germany hopes new Novavax COVID jab might convince vaccine scepticsGermany hopes new Novavax COVID jab might convince vaccine sceptics
Confused about the COVID rules in your area? This app can helpConfused about the COVID rules in your area? This app can help
Germany puts 150 million euros into researching drugs to treat COVIDGermany puts 150 million euros into researching drugs to treat COVID
EU digital COVID certificate launches: What you need to knowEU digital COVID certificate launches: What you need to know
Germany's CureVac vaccine posts just 47 percent efficacyGermany's CureVac vaccine posts just 47 percent efficacy
Germany begins rollout of digital vaccine certificate: What you need to knowGermany begins rollout of digital vaccine certificate: What you need to know
For expats of all colours, shapes and sizes

Explore
Expat infoCareerHousingEducationLifestyleExpat servicesNews & articles
About us
IamExpat MediaAdvertisePost a jobContact usImpressumSitemapRSS feeds
More IamExpat
IamExpat Job BoardIamExpat HousingIamExpat FairWebinarsNewsletters
Privacy
Terms of usePrivacy policyCookiesAvoiding scams

Never miss a thing!Sign up for expat events, news & offers, delivered once a week.
Keep me updated with exclusive offers from partner companies
By signing up, you agree that we may process your information in accordance with our privacy policy


© 2025 IamExpat Media B.V.
© 2025 IamExpat Media B.V.
Jan 6, 2021
Abi Carter

Editor in chief at IamExpat Media

Abi studied German and History at the University of Manchester and has since lived in Berlin, Hamburg and Utrecht, working since 2017 as a writer, editor and content marketeer. Although she's happily taken on some German and Dutch quirks, she keeps a stash of Yorkshire Tea on hand, because nowhere does a brew quite like home.Read more

In what could represent a massive step in the vaccination campaign against coronavirus in Europe, the Moderna vaccine has become the second jab to receive conditional marketing approval from the European Medicines Agency. The vaccine is more expensive, but presents fewer logistical challenges. 

European Medicines Agency recommends approval of Moderna vaccine

A second coronavirus vaccine looks set to gain approval within the European Union. The European Medicines Agency (EMA) has given the green light to the Modern vaccine, after the EMA’s Committee For Medicinal Products for Human Use recommended conditional approval. A final decision must now be made by the European Commission, although their consent is largely a formality.

If approved, the vaccine would become the second COVID-19 vaccine approved for use in the European Union, after the BioNTech / Pfizer vaccine was given the go-ahead at the end of last year. The BioNTech / Pfizer vaccine received fast-track authorisation from the EMA on December 21, but supply chain issues and a low production capacity have massively impeded the rollout of mass vaccinations across the EU. 

The EMA had been expected to announce their decision on the Moderna vaccine following a meeting on Monday - after EU countries put pressure on the organisation to bring forward the date of a possible judgement by a week - but that meeting proved inconclusive. The outcome was instead announced on Wednesday.

📢 EMA has recommended granting a conditional marketing authorisation for COVID-19 Vaccine Moderna to prevent #COVID19 in people from 18 years of age: https://t.co/l9KMZlx7wa pic.twitter.com/BdvXanjOHN

— EU Medicines Agency (@EMA_News) January 6, 2021

Welcome news for Germany’s government

After a difficult few weeks that have seen the German government and the European Commission come under heavy fire for their overly-bureaucratic decision-making processes and slow vaccine rollout programmes, the news is very welcome. 

In clinical trials, the Moderna vaccine - which has already been authorised for use in the US, Canada and Israel - has demonstrated a similar level of effectiveness as the BioNTech / Pfizer vaccine, but has the logistical advantage that it can be stored at a temperature of minus 20 degrees instead of minus 70 degrees. 

However, the European Union has ordered comparatively few doses of the US vaccine. Back in the autumn, Brussels signed a supply contract with Moderna - as it did with five other vaccine manufacturers. Accordingly, Moderna will deliver 80 million vaccine doses to the EU upon approval. 

The Commission has already activated an option included in the supply contract for a further 80 million doses, but the numbers still seem small in comparison to the 200 million doses coming from BioNTech / Pfizer, and the 300 million doses the bloc has secured of the AstraZeneca vaccine - which is yet to receive approval. 

By Abi Carter